Open Radical Cystectomy versus Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Early Outcomes of a Single-Center Randomized Controlled Trial.

Journal: The Journal of urology
Published Date: Feb 2, 2022

Abstract

PURPOSE: Radical cystectomy (RC) with urinary diversion (UD) is still considered a complex surgery associated with significant morbidity. Open RC (ORC) remains the reference option of treatment, even if adoption of robot-assisted RC (RARC) is rapidly increasing. To date, all the available randomized controlled trials were characterized by an extracorporeal approach in performing UD, undermining potential benefits of a totally minimally invasive procedure. In this study, we aimed to report perioperative and 6-month outcomes from the first RCT comparing ORC and RARC with totally intracorporeal UD.

Authors

  • Riccardo Mastroianni
    Complex Operative Unit of Urology, Campus Bio-Medico University of Rome, Rome, Italy.
  • Mariaconsiglia Ferriero
    Department of Urology, Regina Elena National Cancer Institute, Rome, Italy.
  • Gabriele Tuderti
    Department of Urology, Regina Elena National Cancer Institute, Rome, Italy.
  • Umberto Anceschi
    Department of Urology, Regina Elena National Cancer Institute, Rome, Italy. Electronic address: umberto.anceschi@gmail.com.
  • Alfredo Maria Bove
    Department of Urology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Aldo Brassetti
    Fondazione Vincenzo Pansadoro, Centro di Urologia Laparoscopica e Oncologia Medica, Rome, Italy. Electronic address: aldo.brassetti@gmail.com.
  • Leonardo Misuraca
    Department of Urology, Regina Elena National Cancer Institute, Rome, Italy.
  • Ashanti Zampa
    Department of Clinical Trials, Biostatistics and Bioinformatics, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Giulia Torregiani
    Department of Anesthesiology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Edoardo Ghiani
    IRCCS "Regina Elena" National Cancer Institute, Department of Urology, Rome, Italy.
  • Diana Giannarelli
    Department of Clinical Trials, Biostatistics and Bioinformatics, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Salvatore Guaglianone
    Department of Urology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Michele Gallucci
    Department of Urology, La Sapienza University, Rome, Italy.
  • Giuseppe Simone
    Department of Urology, Regina Elena National Cancer Institute, Rome, Italy.

Keywords

External Resources

Popular Topics
Recent Journals